$LJPC LA JOLLA PHARMACEUTICAL CO Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in LA JOLLA PHARMACEUTICAL CO. Find out how many shares they currently own, their value and whether they buy or sell their shares.
LA JOLLA PHARMACEUTICAL CO Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ADAMS THOMAS PHD | Director | 0 | 0 | May 23 2008 | |||
| BENNETT BRUCE K JR | VP of Manufacturing | 12,836 | 249,917 | Apr 18 2006 | |||
| BIOMARIN PHARMACEUTICAL INC | 10% Owner | 4,466,387 | 86,960,555 | Jun 19 2009 | |||
| CARVER JENNIFER | Chief Operating Officer | 14,049 | 273,534 | Mar 04 2019 | |||
| CAVIAR NIV EDWARD | Chief Business Officer & CFO | 0 | 0 | Jan 23 2009 | |||
| Chawla Lakhmir S | Chief Medical Officer | 13,447 | 261,813 | Sep 17 2020 | |||
| Douglass Laura L. | Director | 500 | 9,735 | Dec 14 2020 | |||
| Douglass Laura L. | Director | 0 | 0 | Apr 07 2014 | |||
| Edwards Larry G. | Chief Executive Officer | 984 | 19,158 | May 18 2021 | |||
| Elchico Josefina T | VP Quality Operations | 0 | 0 | Mar 05 2009 | |||
| ENGBERS WILLIAM | Director | 0 | 0 | May 20 2005 | |||
| ENGLE STEVEN B | CEO & Chairman | 147,084 | 2,863,725 | Dec 15 2005 | |||
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | 10% Owner | 7,666,666 | 149,269,987 | Apr 12 2007 | |||
| ESSEX WOODLANDS HEALTH VENTURES FUND VI L P | 10% Owner | 0 | 0 | Aug 07 2009 | |||
| ESSEX WOODLANDS HEALTH VENTURES FUND VII LP | 10% Owner | 0 | 0 | Aug 07 2009 | |||
| FILDES ROBERT PHD | Director | 0 | 0 | Feb 27 2009 | |||
| FILDES ROBERT PHD | Director | 0 | 0 | Jun 02 2010 | |||
| Frazier Healthcare V, LP | 10% Owner | 4,833,333 | 94,104,994 | Apr 09 2007 | |||
| Frazier Healthcare V, LP | 10% Owner | 5,470,555 | 106,511,706 | Feb 26 2009 | |||
| Gillespie Deirdre | President & CEO | 0 | 0 | Jan 23 2009 | |||
| Gillespie Deirdre | President & CEO | 0 | 0 | May 18 2011 | |||
| Gonzalez Alejandro | 10% Owner | 6,864,720 | 133,656,098 | Feb 04 2005 | |||
| Gonzalez Alejandro | 10% Owner | 4,596,495 | 89,493,758 | Jan 10 2007 | |||
| Gonzalez Alejandro | 10% Owner | 5,429,828 | 105,718,751 | Apr 09 2007 | |||
| Gonzalez Alejandro | 10% Owner | 0 | 0 | Feb 13 2009 | |||
| Gonzalez Alejandro | 10% Owner | 8,205,692 | 159,764,823 | May 15 2008 | |||
| Hearne Michael S | Chief Financial Officer | 3,934 | 76,595 | Jun 02 2021 | |||
| HEILBRUNN KENNETH R | VP of Clinical Development | 12,155 | 236,658 | Apr 05 2005 | |||
| JENN PAUL | VP of Product Development | 350 | 6,815 | Jan 11 2007 | |||
| Johnson Craig A | Director | 0 | 0 | Dec 14 2020 | |||
| Johnson Craig A | Director | 0 | 0 | Nov 26 2013 | |||
| Johnson Craig A | Director | 0 | 0 | Apr 07 2014 | |||
| KOCH LISA I | VP Regulatory & Project Mgmt. | 6,350 | 123,635 | Feb 07 2007 | |||
| LA JOLLA PHARMACEUTICAL CO | 10% Owner | 4,822,360 | 93,891,349 | Jul 29 2020 | |||
| LINNIK MATTHEW D | CSO & Exec VP of Research | 1,300 | 25,311 | Dec 27 2006 | |||
| MARTIN STEPHEN | Director | 0 | 0 | May 23 2008 | |||
| MARTIN STEPHEN | Director | 0 | 0 | Jun 02 2010 | |||
| MULROY DENNIS | Chief Financial Officer | 5,067 | 98,654 | Jun 02 2020 | |||
| Naini Nader J | Director | 4,833,333 | 94,104,994 | May 24 2007 | |||
| PERCEPTIVE ADVISORS LLC | 10% Owner | 3,881,967 | 75,581,897 | Jan 09 2019 | |||
| RAMSAY DAVID A | Director | 48,000 | 934,560 | Dec 14 2020 | |||
| REILLY TEDDI | VP of Human Resources | 5,330 | 103,775 | Apr 18 2006 | |||
| RINGO WILLIAM R | Director | 0 | 0 | May 25 2004 | |||
| Rolke James | Chief Scientific Officer | 81,771 | 1,592,081 | Jun 02 2020 | |||
| Rosen Robert | Director | 0 | 0 | Dec 14 2020 | |||
| Rosen Robert | Director | 0 | 0 | Jul 08 2014 | |||
| SEIKKULA LUKE | Vice President Manufacturing | 0 | 0 | Jan 23 2009 | |||
| SLOAN GAIL A | VP of Finance | 0 | 0 | Jun 25 2009 | |||
| SLOAN GAIL A | Chief Financial Officer | 980 | 19,081 | Apr 21 2011 | |||
| SMITH CRAIG R | Director | 0 | 0 | Feb 27 2009 | |||
| SUTTER MARTIN P | Director | 7,666,666 | 149,269,987 | May 23 2008 | |||
| SUTTER MARTIN P | Director | 33,333,334 | 649,000,013 | Dec 16 2005 | |||
| SUTTER MARTIN P | Director | 0 | 0 | Aug 07 2009 | |||
| TANG KEVIN C | Director | 9,194,673 | 179,020,283 | May 04 2021 | |||
| TANG KEVIN C | Director | 2,101,547 | 40,917,120 | Dec 18 2014 | |||
| TANSEY MICHAEL JAMES BYRON | Executive VP & CMO | 1,900 | 36,993 | Jan 23 2009 | |||
| THOMPSON W LEIGH MD PHD | 0 | 0 | May 25 2004 | ||||
| TIDMARSH GEORGE F | President, CEO & Secretary | 1,263,895 | 24,608,036 | Apr 17 2019 | |||
| TIDMARSH GEORGE F | President, CEO & Secretary | 1,421,086 | 27,668,544 | Dec 12 2014 | |||
| TIDMARSH GEORGE F | Pres, CEO, Sec'y | 68,332,871 | 1,330,440,998 | Oct 11 2013 | |||
| TIDMARSH GEORGE F | President and CEO | 1,180,442 | 22,983,206 | Apr 12 2012 | |||
| TIDMARSH GEORGE F | President and CEO | 1,980,442 | 38,559,206 | May 01 2013 | |||
| TIDMARSH GEORGE F | President, CEO & Secretary | 4,000 | 77,880 | Apr 14 2014 | |||
| Topper James N | Director | 4,833,333 | 94,104,994 | May 23 2008 | |||
| Topper James N | Director | 0 | 0 | Feb 26 2009 | |||
| WELCH WILLIAM J | VP Sales & Marketing | 893 | 17,387 | May 20 2005 | |||
| Wellinghoff Darryl | Chief Commercial Officer | 9,504 | 185,043 | Apr 17 2020 | |||
| WISEMAN ANDREW | Sen Dir Investor Relations | 16,613 | 323,455 | Feb 07 2007 | |||
| YOUNG FRANK | Director | 0 | 0 | May 23 2008 | |||
| Zarrabian Saiid | Director | 688 | 13,395 | May 15 2015 | |||
| Zarrabian Saiid | Director | 5,461,588 | 106,337,118 | Nov 26 2013 | |||
| Zarrabian Saiid | Director | 11,541,334 | 224,709,773 | Apr 12 2012 | |||
| Zarrabian Saiid | Director | 381 | 7,418 | Aug 05 2014 |